Overview

Maverick Simulation Solutions is a medtech startup that focuses on creating medical training gears, simulators and training room for universities and hospitals. Established in September 2023, Maverick has 13 years of expertise in 3D printing and scanning business. 

Origin of Maverick dates back to 2006 when Anuj incorporated – Maverick solutions Inc. with the goal of providing latest technology to its customers while inspiring the next generation. 

Throughout the years, he spotted a much bigger opportunity – India’s medical colleges and hospitals lack the access to world class equipment and it needs real world simulations and training rooms to enhance skills of professionals before they attend an actual case. With this view, he shifted his focus towards medical simulation and introduced Anatomage Table in 2018. 

Since then, Maverick has established a robust and highly motivated team of R&D that created a diverse portfolio featuring 40+ products, with 200+ serviced customers. Medical simulators range from low-fidelity models for basic training to high-fidelity simulators replicating real life medical cases. 

Maverick is a bootstrapped startup and founders have invested 50+ Cr in research and development. The company has not raised any external funding but its shares are traded in unlisted market, its market capitalization has crossed 1100 Cr. 

What maverick Does? 

Operational Model

Maverick runs on hybrid distribution model – where it acts as both distributor of globally renowned technology and in-house producer of alternatives. 

Maverick has two business segments:

1. Distribution: Here maverick import the globally renowned technology such as Anatomage table, KeyShot, Rhino and distribute in India 

2. In-House Manufacturer: Maverick has invested heavily in its R&D to manufacture its own simulators and equipment. 

How does NERL make Money?

Maverick makes money by offering following solutions:
Medical Solutions

• Autonomous Human Lung Simulator

• Patent Simulator

• Surgery Simulator

• Anatomage Table 

• Task Trainer 

• Turnkey Projects 

SimAcademy – a specialized healthcare training centers, offering simulation-based training in:

• IVFSim Pro – Training for fertility treatment

• NurseSim Pro – Hands on practice on technical skills for nurses 

• VentilateSim Pro – Specilazed training for mechanical ventilation 

• FaceSim Pro – Training focused on facial aesthetics, cosmetic procedure and laproscopy.

Apart form this Maverick also provides access to softwares such as:

• KeyShot Studio

• Rhino 3D

• Cascadeur

Analysis Points:

• Mavericks Revenue is highly concentrated in one-time high ticket equipment sale and laboratory set up projects

• Revenue numbers have proved the pattern of hardware-heavy capital equipment business – a massive 10x jump in revenue 14.2 Cr in FY24 to 136.3 Cr in FY25

• Growth Drivers:

  • Government mandates acting as legal catalyst – NMC has directed its necessity 

  • Institutional adoption – medical colleges embracing the technology

Competitors

Maverick faces dual competition but dominates in a highly niche market, at the domestic level its competitors are:

1. Direct Competitors (Innovators & Manufacturer)

Like Maverick, following companies also innovate and manufacture medical simulators and equipment within India:

• Satej Medinova Medical Device Company

• Trishula Technologies 

1. Distributor Competitors (Global Tech)

Indian medical college and hospitals lack the advanced infra and tech required in medical or healthcare space, Like Maverick following companies do not manufacture simulators but competes aggressively for government tenders.

• Madekom Medical System 

• Laerdal Medical India

• Vardhan Medical Systems

Analysis Points:

• Maverick heavily depends upon its institutional clients 

• Pressure from global leaders may disrupt the supply 

• Extended complex sales cycles make the business capex heavy with long receivables 

• Speculative domestic players competes aggressively on prices

Funding & Valuations

Maverick Simulations is a prominent bootstrapped startup in Indian Medtech space. Instead of relying on external funding to pump up its valuation and grow, founders are investing their own money. 

• Recent Investment in R&D – INR 50+ Cr

• Revenue trajectory – FY24: INR 14.2 Cr Vs FY25: 136.3 Cr

• PAT – FY24: 0.94 Cr Vs FY25: 47.8 Cr